mCICR is required for As2O3-induced permeability transition pore opening and cytochrome c release from mitochondria

Molecular and Cellular Biochemistry

Volumn 277, Issue 1-2, 2005, Pages 33-42

  Tian, Xuemei ^a   Ma, Xiaodong ^a   Qiao, Dongfang ^a   Ma, Ande ^a   Yan, Fang ^a   Huang, Xingxu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; As2O3; Calcium transport; Cytochrome c; Mitochondria; Permeability transition pore

Indexed keywords

APOPTOSIS INDUCING FACTOR; ARSENIC TRIOXIDE; CALCIUM ION; CYTOCHROME C; CARRIER PROTEIN; ION CHANNEL; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; ORGANOARSENIC DERIVATIVE; OXIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN SECRETION; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; CALCIUM SIGNALING; DRUG EFFECT; IN VITRO STUDY; KINETICS; LIVER MITOCHONDRION; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; APOPTOSIS; ARSENICALS; CALCIUM SIGNALING; CYTOCHROMES C; FEMALE; ION CHANNELS; KINETICS; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; OXIDES; RATS; RATS, WISTAR;

EID: 24144448091     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-4818-x     Document Type: Article

References (53)

1. Aposhian HV: Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 37: 397-419, 1997 10.1146/annurev.pharmtox.37.1.397
2. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339: 1341-1348, 1998 10.1056/ NEJM199811053391901
3. Evens AM, Tallman MS, Gartenhaus RB: The potential of arsenic trioxide in the treatment of malignant disease: Past, present, and future. Leuk Res 28(9): 891-900, 2004 10.1016/j.leukres.2004.01.011
4. Chou WC, Dang CV: Acute promyelocytic leukemia: Recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol 12(1): 1-6, 2005 10.1097/01.moh.0000148552.93303.45
5. 3) induces NB4 cell apoptosis with down-regulation of bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88: 1052-1061, 1996 8704214
6. Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann OG, Ruthardt M: PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol 7: 5170-5178, 1999
7. Konig A, Wrasel L, Warrell RP, Rivi R, Pandolfi PP, Jakubowski A, Gabrilove JL: Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood 90: 562-570, 1997 9226155
8. Akao Y, Mizoguchi H, Kojima S, Naoe T, Ohishi N, Yagi K: Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: Activation of caspases and down-regulation of Bcl-2 protein. Br J Haematol 102: 1055-1060, 1998 10.1046/j.1365-2141.1998.00869.x
9. AkaoY, NakagawaY, Akiyama K: Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett 455(1-2): 59-62, 1999 10.1016/S0014-5793(99)00841-8
10. Woo SH, Park IC, Park MJ, Lee SJ, Chun YJ, Lee SH, Hong SI, Rhee CH: Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in Hela cells. Int J Oncol 21(1): 57-63, 2002 12063550
11. 3) on human breast cancer cells. J Cell Biochem 93(1): 173-187, 2004 10.1002/ jcb.20102
12. Wang ZG, Rivi R, Delva L, Konig A, Scheinberg DA, Gambacorti-Passerini C, Gabrilove JL, Warrell RP, Pandolfi PP: Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemic cell lines and function in a PML and PML-RAR alpha independent fashion. Blood 92: 1497-1504, 1999
13. Mirkes PE, Little SA: Teratogen-induced cell death in postimplantation mouse embryos: Differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ 5: 592-600, 1999 10.1038/sj.cdd.4400390
14. Chen YC, Lin Shiau SY, Lin JK: Involvement of reactive oxygen species and caspase3 activation in arsenite-induced apoptosis. J Cell Physiol 177: 324-333, 1998 10.1002/ (SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9
15. Choi YJ, Park JW, Suh SI, Mun KC, Bae JH, Song DK, Kim SP, Kwon TK: Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt. Int J Oncol 21: 603-610, 2002 12168106
16. Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W, Keating MJ, Huang P: Inhibition of mitochondrial respiration a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 278(39): 37832-37839, 2003 10.1074/jbc.M301546200
17. Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P: Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. Leukemia 14: 1006-1134, 2000 10.1038/sj.leu.2401800
18. 2+-dependent production of superoxide. Int J Cancer 92(4): 518-526, 2001 10.1002/ijc.1220
19. Doza YN, Hall-Jackson CA, Cohen P: Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of GrB2-Sos. Oncogene 17: 19-24, 1998 10.1038/sj.onc.1202168
20. Quignon F, DeBels F, Koken M, Feunteun J, Ameisen JC, Dethe H: PML induces a novel caspase-independent death process. Nat Genet 20: 259-265, 1998 10.1038/3068
21. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed JC, Kroemer G: Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp Cell Res 249: 413-421, 1999 10.1006/excr.1999.4519
22. Sordet O, Rebe C, Leroy I, Bruey JM, Garrido C, Miguet C, Lizard G, Plenchette S, Corcos L, Solary E: Mitochondra-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood 97: 3931-3940, 2001 10.1182/ blood.V97.12.3931
23. Zoratti M, Szabo I: The mitochondrial permeability transition. Biochem Biophys Acta 1241: 139-176, 1995 7640294
24. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614-620, 1997 10.1038/nm0697-614
25. 2+ transport and permeability transition pore opening and mitochondria energetic status. Mol Cell Biochem 224: 1-7, 2001 10.1023/A:1011990300114
26. 2+ regulation in neuronal and glial cell signaling. Brain Res Rev 26: 72-81, 1998 10.1016/S0165-0173(97)00056-8
27. 2+ signaling and apoptosis. J Bioenerg Biomembr 32: 35-46, 2000 10.1023/ A:1005508311495
28. Ichas F, Jouaville LS, Mazat JP: Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell 89: 1145-1153, 1997 10.1016/S0092-8674(00)80301-3
29. Ichas F, Mazat JP: From calcium signaling to cell death: Two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochem Biophys Acta 1366: 33-50, 1998 9714722
30. Huang X, Zhai D, Huang Y: Study on the relationship between calcium-induced calcium release from mitochondria and PTP opening. Mol Cell Biochem 213: 29-35, 2000 10.1023/A:1007138818124
31. Broekemeier KM, Klocek CK, Pferfer DR: Proton selective substate of mitochondrial permeability pore: Regulation by the redox state of the electron transport chain. Biochemistry 37: 13059-13065, 1998 10.1021/ bi980820c
32. Petronilli V, Szabo I, Zoratti M: The inner mitochondrial membrane contains ion conducting channels similar to those found in bacteria. FEBS Lett 259: 137-143, 1989 10.1016/0014-5793(89)81513-3
33. Emaus RK, Grunwald R, Lemasters JJ: Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: Spectral and metabolic properties. Biochim Biophys Acta 850(3): 436-448, 1986 2873836
34. Frei B, Winterhalter KH, Richter C: Mechanism of alloxan-induced calcium release from liver mitochondria. J Biol Chem 260: 7394-7401, 1985 3158657
35. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998 9727491
36. Lenartowicz E, Bernardi P, Azzone GF: Phenylarsine oxide induces the cyclosporine-A-sensitive membrane permeability transition in rat liver mitochondria. J Bioenerg Biomembr 23: 679-688, 1991 10.1007/BF00785817
37. Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabo I, Zoratti M: Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J Biol Chem 267: 2934-2939, 1992
38. Pastorino JG, Snyder JW, Serroni A, Hoek JB, Farber JL: Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem 268: 13791-13798, 1993 8314748
39. Connern CP, Halestrap AP: Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem J 302: 321-324, 1994 7522435
40. Petronilli V, Costantini P, Scorrano L, Colonna R, Passamonti S, Bernardi P: The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J Biol Chem 269: 16638-16642, 1994 7515881
41. Costantini P, Chernyak BV, Petronilli V, Bernardi P: Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271: 6746-6751, 1996 10.1074/jbc.271.12.6746
42. 2+ signaling. Curr Opin Neurobiol 8: 398-404, 1998 10.1016/ S0959-4388(98)80067-6
43. Gunter TE, Gunter KK, Sheu SS, Gavin CE: Mitochondrial calcium transport: Physiological and pathological relevance. Am J Physiol 267: C313-C319, 1994 8074170
44. Hoyt KR, Sharma TA, Reyndds I: Trifluoperazine and dibucaine-induced inhibition of glutamate-induced mitochondria depolarization in rat cultured forebrain neurons. Br J Pharmacol 122(5): 803-808, 1997 10.1038/ sj.bjp.0701442
45. Susin SA, Zamzami N, Kroemer G: L Mitochondria as regulators of apoptosis: Doubt no more. Biochim Biophys Acta 1366(1-2): 151-165, 1998 9714783
46. Green DR., Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998 9721092
47. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B: The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochem Biophys Acta 1366(1-2): 177-196, 1998 9714796
48. Bernardi P: Mitochondrial transport of cations: Channels, exchangers and permeability transition. Physiol Rev 79: 1127-1155, 1999 10508231
49. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297(5579): 259-263, 2002 10.1126/science.1072221
50. 2+: Correlation with mitochondrial permeability transition. Biochem Biophys Acta 1318: 395-402, 1997 9048976
51. Woodfield K, Ruck A, Brdiczka D, Halestrap AP: Direct demonstration of a specific interaction between cyclophilin-D and the ademine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 336: 287-290, 1998 9820802
52. 2+ threshhold for the mitochondrial permeability transition and the content of proteins related to Bcl-2 in rat liver and Zajdela hepatoma mitochondria. Mol Cell Biochem 194: 251-256, 1999 10.1023/A:1006913526643
53. Argaud L, Gateau-Roesch O, Chalabreysse L, Goemez L, Loufouat J, Thivolet-Bejui F, Robert D, Ovize M: Preconditioning delays - induced mitochondrial permeability transition. Cardiovasc Res 61(1): 115-122, 2004 10.1016/j.cardiores.2003.11.003